Biosimilars 101
To help clients prepare for the wave of biosimilars on the horizon, we answer some basic questions about these potentially game-changing medications.
Read MoreHow Accredo’s physician engagement team simplifies the experience for prescribers
The team focuses on highly complex medications, including treatments for cancer, neurological diseases, pulmonary conditions, and bleeding disorders.
Read MoreHow to Prevent a Spike in Lung Cancer Diagnoses
Despite a decline in overall cancer deaths attributed to a decrease in smoking, trends indicate a potential new surge.
Read MoreThree Ways to Help Your Members Avoid Interrupted Fertility Treatment
A well-designed fertility benefit helps members stay on treatment, reducing wasted dollars
Read MoreHow to improve specialty drug adherence for patients with inflammatory conditions
To mitigate nonadherence for inflammatory condition treatments, plan sponsors should adopt a multifaceted approach that combines clinical protocols and value-based solutions.
Read MoreEnhancing recruitment for local clinical drug trials
During the panel, experts discussed ways they have navigated patient recruitment challenges.
Read MoreTransforming oncology care through a holistic, patient-centric, and consultative approach
Evernorth Health Services has introduced Evernorth Oncology Benefit Services, which will be available to eligible commercial plan sponsors in 2025, with plans to expand over time.
Read MoreFour Considerations for Designing a Fertility Benefit
The right fertility benefit provides the right treatment to meet each individual member’s needs while delivering value to the plan.
Read MoreTwo Ways to Assess the Holistic Value of Your Specialty Partner
Getting the most value out of your specialty drug management partner starts with asking the right questions.
Read More